Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay

PLoS ONE

Volumn 12, Issue 7, 2017, Pages

  Catarino, Rosa ^a   Vassilakos, Pierre ^b   Bilancioni, Aline ^a   Bougel, Stéphanie ^c   Boukrid, Meriem ^a   Meyer Hamme, Ulrike ^a   Petignat, Patrick ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b WHO Collaborating Centre in Education and Research in Human Reproduction   (Switzerland)

^c Biopath Lab   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EDUCATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PAPILLOMAVIRUS INFECTION; POINT OF CARE SYSTEM; POLYMERASE CHAIN REACTION; RAPID TEST; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; SWITZERLAND; VAGINA SMEAR; VAGINAL DRY SWAB; VIRUS DETECTION; WART VIRUS; ADOLESCENT; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SPECIMEN HANDLING; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SPECIMEN HANDLING; VAGINAL SMEARS; YOUNG ADULT;

EID: 85026659141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0181905     Document Type: Article

References (21)

1. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012; 30:F88–F99. https://doi.org/10.1016/j.vaccine.2012.06.095 PMID: 23199969
2. Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. The lancet. 2014; 383(9916):524–32.
3. Castle PE, de Sanjosé S, Qiao Y-L, Belinson JL, Lazcano-Ponce E, Kinney W. Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine. 2012; 30:F117–F22. https://doi.org/10.1016/j.vaccine.2012.05.071 PMID: 23199954
4. WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva, Switzerland: World Health Organization; 2013. Available at http://apps.who.int/iris/bitstream/10665/94830/1/9789241548694_eng.pdf.
5. Sherris J, Wittet S, Kleine A, Sellors J, Luciani S, Sankaranarayanan R, et al. Evidence-based, alternative cervical cancer screening approaches in low-resource settings. International perspectives on sexual and reproductive health. 2009:147–52. https://doi.org/10.1363/ifpp.35.147.09 PMID: 19805020
6. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. New England Journal of Medicine. 2009; 360(14):1385–94. https://doi.org/10.1056/NEJMoa0808516 PMID: 19339719
7. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. The lancet oncology. 2014; 15(2):172–83. https://doi.org/10.1016/S1470-2045(13)70570-9 PMID: 24433684
8. Einstein MH, Smith KM, Davis TE, Schmeler KM, Ferris DG, Savage AH, et al. Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy. Journal of clinical microbiology. 2014; 52(6):2089–95. https://doi.org/10.1128/JCM.00176-14 PMID: 24719440
9. Cuzick J, Cuschieri K, Denton K, Hopkins M, Thorat M, Wright C, et al. Performance of the Xpert HPV assay in women attending for cervical screening. Papillomavirus Research. 2015; 1:32–7.
10. Castle PE, Smith KM, Davis TE, Schmeler KM, Ferris DG, Savage AH, et al. Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population. American journal of clinical pathology. 2015; 143(1):126–33. https://doi.org/10.1309/AJCP4Q0NSDHWIZGU PMID: 25511151
11. Eperon I, Vassilakos P, Navarria I, Menoud P- A, Gauthier A, Pache J- C, et al. Randomized comparison of vaginal self-sampling by standard vs. dry swabs for Human papillomavirus testing. BMC cancer. 2013; 13(1):353.
12. Wolfrum SG, Koutsky LA, Hughes JP, Feng Q, Xi LF, Shen Z, et al. Evaluation of dry and wet transport of at-home self-collected vaginal swabs for human papillomavirus testing. Journal of medical microbiology. 2012; 61(11):1538–45.
13. Catarino R, Vassilakos P, Bilancioni A, Eynde MV, Meyer-Hamme U, Menoud P-A, et al. Randomized Comparison of Two Vaginal Self-Sampling Methods for Human Papillomavirus Detection: Dry Swab versus FTA Cartridge. PloS one. 2015; 10(12):e0143644. https://doi.org/10.1371/journal.pone. 0143644 PMID: 26630353
14. Sultana F, Gertig DM, Wrede CD, English DR, Simpson JA, Drennan KT, et al. A pilot study to compare dry cervical sample collection with standard practice of wet cervical samples for human papillomavirus testing. Journal of Clinical Virology. 2015; 69:210–3. https://doi.org/10.1016/j.jcv.2015.06.080 PMID: 26209409
15. Belinson JL, Du H, Yang B, Wu R, Belinson SE, Qu X, et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. International Journal of Cancer. 2012; 130(8):1855–60. https://doi.org/10.1002/ijc.26202 PMID: 21630255
16. Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening. International journal of cancer. 2013; 132(10):2223–36. https://doi.org/10.1002/ijc.27790 PMID: 22907569
17. Kovacic MB, Castle PE, Herrero R, Schiffman M, Sherman ME, Wacholder S, et al. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Research. 2006; 66(20):10112–9. https://doi.org/10.1158/0008-5472.CAN-06-1812 PMID: 17047075
18. Castle PE, Wheeler CM, Solomon D, Schiffman M, Peyton CL, Group A. Interlaboratory reliability of hybrid capture 2. American journal of clinical pathology. 2004; 122(2):238–45. https://doi.org/10.1309/ BA43-HMCA-J26V-WQH3 PMID: 15323141
19. Heideman D, Hesselink A, Berkhof J, van Kemenade F, Melchers W, Daalmeijer NF, et al. Clinical validation of the cobas® 4800 HPV Test for cervical screening purposes. Journal of clinical microbiology. 2011:JCM. 05552–11.
20. Vassilakos P, Catarino R, Bougel S, Munoz M, Benski C, Meyer-Hamme U, et al. Use of swabs for dry collection of self-samples to detect human papillomavirus among Malagasy women. Infectious Agents and Cancer. 2016; 11(1):1.
21. Agreda PM, Beitman GH, Gutierrez EC, Harris JM, Koch KR, LaViers WD, et al. Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media. Journal of clinical microbiology. 2013; 51(8):2702–6. https://doi.org/10.1128/JCM.00759-13 PMID: 23678069